Cancellation of state registration. Finoptin®

October 18, 2016

Active substances:

Verapamil

Trade names:

Finoptin®

ICD-10:

IX.I10-I15.I10 Essential [primary] hypertension

IX.I20-I25.I20.1 Angina with documented spasm

IX.I20-I25.I20.8 Other forms of angina pectoris

IX.I26-I28.I27.0 Primary pulmonary hypertension

IX.I30-I52.I42 Cardiomyopathy

IX.I30-I52.I45.6 Syndrome of premature agitation

IX.I30-I52.I47.1 Nadzheludochkovaya tachycardia

IX.I30-I52.I48 Atrial fibrillation and flutter

IX.I30-I52.I49.4 Other and unspecified depolarization

Verapamil, Finoptin, calcium channel blockers, angina treatment, cardiomyopathy, ecstasy, atrial fibrillation

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N014974 / 01 from 22.07.2008 issued by Orion Corporation, Finland):

Finoptin® (trade name of the medicinal product)

Verapamil (international non-proprietary or grouping or chemical name)

tablets, 40 mg, 80 mg (dosage form, dosage)

Orion Corporation Orion Pharma, Finland Orionintie 1,02200, Espoo, Finland (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing an application by the authorized legal entity LLC Orion Pharma to cancel the state registration of the medicinal product.